AstraZeneca Pharma (ASTRAZEN) | Stock Overview & Key Data

AstraZeneca Pharma India Ltd. | Large-cap | Healthcare

₹10,260.00

-2.37%

| AstraZeneca Pharma Stock Comparison:

No comparison data available

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

AstraZeneca Pharma Performance Comparison

Loading chart data...

AstraZeneca Pharma

NIFTY 50

View Full Price History

Stock Range

Today's Range

Low: ₹10,207.00 High: ₹10,549.00

on June 16, 2025

52 Week Range

Low: ₹6,069.70 High: ₹10,691.00

on June 26, 2024

on June 13, 2025

All-Time High: ₹10,691.00 on June 13, 2025

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR255.2B

EPS i 45.86

P/E Ratio (TTM) i 222.31

Forward P/E i N/A

P/B Ratio i 33.09

PEG Ratio i -7.85

Div. Yield i 0.32%

ROE i 15.62%

Beta i 0.030

Debt to Equity i 4.64

Financial Highlights

Profitability

Gross Margin i 45.97%

Operating Margin i 14.29%

Profit Margin i 6.74%

Returns and Earnings

Return on Assets (TTM) i 10.30%

Return on Equity (TTM) i 15.62%

EBITDA i INR2.9B

Net Income (TTM) i INR1.2B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i ₹24.00

Estimated Dividend Yield i 0.24%

5 Year Average Dividend Yield i 0.20%

Last 12-Month Dividend Yield i 0.32%

Last 12-Month Dividend i ₹32.00

% of Earnings Paid as Dividends i 51.84%

Dividend Date i N/A

Ex-Dividend Date i July 5, 2024

Peer Performance Comparison

No peer performance data available for this stock.

Ownership & Short Interest

Insider Ownership i 81.59%

Institutional Ownership i 7.30%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 308K

Average 90-Day Volume i 112K

AstraZeneca Pharma Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in AstraZeneca Pharma would have performed over time.

Investment Amount

INR

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is ASTRAZEN's 52-week high and low?

In the last 52 weeks, AstraZeneca Pharma reached a high of ₹10,691.00 (on June 13, 2025) and a low of ₹6,069.70 (on June 26, 2024).

What is the market cap and P/E ratio for ASTRAZEN?

Curious about AstraZeneca Pharma's size and valuation? Its market capitalization stands at 255.19B. When it comes to valuation, the P/E ratio (trailing twelve months) is 222.31, and the forward P/E (looking ahead) is N/A.

Does ASTRAZEN pay dividends? If so, what's the yield?

Yes, AstraZeneca Pharma is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.32%, and the company is expected to pay out ₹24.00 per share over the coming year.

Who are AstraZeneca Pharma's main competitors or similar companies to consider before investing?

When looking at AstraZeneca Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

No specific competitor data is currently available for comparison in this section.

What are the key financial health indicators for AstraZeneca Pharma India Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of AstraZeneca Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.62%, the Debt to Equity ratio from the most recent quarter is 4.64, and its Gross Profit Margin stands at 45.97%.

What is the recent revenue and earnings growth for ASTRAZEN?

Looking at AstraZeneca Pharma's growth, its revenue over the trailing twelve months (TTM) was INR17B. Compared to the same quarter last year (YoY), quarterly revenue grew by 25.40%, and quarterly earnings saw a YoY growth of 47.50%.

How much of ASTRAZEN stock is held by insiders and institutions?

Wondering who owns AstraZeneca Pharma stock? Company insiders (like executives and directors) hold about 81.59% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 7.30%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.